emerg
infecti
diseas
eid
wildlif
major
threat
human
health
biodivers
conserv
estim
zoonot
eid
event
caus
pathogen
wildlif
incid
diseas
increas
significantli
human
addit
human
diseas
start
infect
wildlif
especi
nonhuman
primat
chimpanze
endang
speci
threaten
human
activ
deforest
poach
human
diseas
transmiss
recent
sever
respiratori
diseas
outbreak
suspect
transmit
human
report
wild
chimpanze
therefor
need
studi
zoonot
pathogen
threaten
captiv
chimpanze
primat
research
institut
serolog
surveil
one
sever
method
use
reveal
infect
histori
examin
serum
captiv
chimpanze
japanes
primat
research
institut
antibodi
human
pathogen
chimpanzeeborn
infecti
diseas
antibodi
test
posit
pathogen
high
low
preval
chimpanze
result
suggest
proport
humanborn
infect
may
reflect
chimpanze
histori
manag
system
institut
region
epidem
furthermor
captiv
chimpanze
highli
suscept
human
pathogen
induc
antibodi
reveal
histori
infect
also
possibl
protect
human
pathogen
emerg
infecti
diseas
eid
wildlif
may
aris
result
complex
relationship
social
environment
factor
major
threat
human
health
biodivers
conserv
daszak
et
al
daszak
et
al
jone
et
al
mcmichael
moren
et
al
diseas
often
reduc
wildlif
popul
isol
commun
eg
ebola
outbreak
gorilla
chimpanze
gabon
congo
increas
probabl
extinct
especi
frequencydepend
outbreak
de
castro
bolker
gerber
et
al
bermejo
et
al
nunn
et
al
eid
event
caus
zoonot
pathogen
nonhuman
anim
sourc
taylor
et
al
woolhous
gowtagesequeria
jone
et
al
moreov
estim
zoonot
event
caus
pathogen
origin
wildlif
exampl
emerg
nipah
viru
perak
malaysia
sever
acut
respiratori
syndrom
sar
guangdong
provinc
china
pathogen
origin
wildlif
also
increas
significantli
time
jone
et
al
support
suggest
zoonot
eid
increas
signific
threat
global
health
moren
et
al
weiss
mcmichael
king
et
al
also
emphas
import
understand
factor
increas
contact
wildlif
human
develop
predict
approach
diseas
emerg
daszak
et
al
patz
et
al
human
infecti
diseas
also
increasingli
transmit
wildlif
especi
nonhuman
primat
chimpanze
human
close
relat
speci
evolutionarili
genet
anatom
physiolog
characterist
also
immunolog
featur
much
similar
anim
brack
woodford
et
al
clark
et
al
wild
chimpanze
may
suscept
human
infecti
diseas
immun
system
may
protect
human
pathogen
accord
recent
report
addit
poach
habitat
fragment
deforest
humanborn
diseas
epidem
spread
ecotour
contribut
declin
wild
chimpanze
popul
kaiser
whitfield
kondgen
et
al
unknown
respiratori
diseas
also
report
chimpanze
resid
protect
area
includ
bossou
guinea
gomb
mahal
tanzania
result
chimpanze
death
suspect
transmit
human
goodal
hosaka
ferber
nishida
et
al
matsuzawa
et
al
hanamura
et
al
infecti
diseas
transmiss
possibl
without
close
contact
via
sneez
cough
etc
muehlenbein
ancrenaz
report
speci
pathogen
recov
throat
swab
tourist
view
orangutan
reveal
possibl
mani
humanborn
agent
may
transmit
ape
sever
mode
infect
therefor
continu
health
monitor
investig
humanborn
infecti
diseas
ape
need
risk
manag
studi
sought
serolog
evid
zoonos
captiv
chimpanze
kyoto
univers
primat
research
institut
kupri
japan
obtain
basic
epidemiolog
inform
zoonos
affect
wild
chimpanze
africa
prevent
pandem
outbreak
chimpanze
examin
studi
rear
year
sinc
birth
kupri
approxim
year
introduct
zoo
western
africa
individu
cage
rather
social
group
wild
therefor
good
model
wild
chimpanze
studi
studi
conduct
guidelin
kupri
obtain
approv
institut
anim
welfar
care
committe
serolog
surveil
conduct
chimpanze
year
old
kept
indooroutdoor
enclosur
kupri
see
matsuzawa
matsuzawa
inform
anim
inform
chimpanze
summaris
tabl
chimpanze
subject
behaviour
psycholog
evolutionari
studi
summaris
tabl
pendesa
suffer
allerg
dermat
mari
reiko
sever
cold
respect
reo
develop
tetraparesi
resembl
acut
transvers
myeliti
miyabenishiwaki
et
al
pal
cleo
ayumu
pan
reo
popo
born
kupri
pendesa
born
anoth
institut
japan
transfer
kupri
year
old
mari
akira
born
africa
rear
institut
japan
transfer
kupri
chloe
born
french
zoo
puchi
gon
born
africa
rear
pet
japan
ai
reiko
transport
directli
africa
health
anim
monitor
daili
keeper
individu
underw
period
health
examin
everi
year
none
chimpanze
vaccin
pathogen
sampl
collect
april
februari
chimpanze
anaesthetis
research
purpos
period
health
examin
chimpanze
anaesthetis
combin
mgkg
ketamin
hydrochlorid
ketalar
sankyo
park
davi
japan
mgkg
medetomidin
hydrochlorid
domitor
meiji
seika
kaisha
tokyo
japan
without
premed
oral
midazolam
mgkg
droperidol
mgkg
anaesthesia
maintain
isofluran
isoflu
dainippon
sumitomo
pharma
osaka
japan
necessari
blood
sampl
collect
plain
tube
coagul
serum
plasma
separ
centrifug
min
analys
within
day
store
serolog
test
perform
human
respiratori
syncyti
viru
rsv
human
metapneumoviru
hmpv
serolog
analys
conduct
viru
research
centr
sendai
medic
centr
sendai
japan
okamoto
et
al
analys
outsourc
tokai
chuo
laboratori
falco
biosystem
kyoto
japan
corpor
product
research
laboratori
primat
tsukuba
japan
hbv
test
conduct
esplin
hbsn
fujirebio
diagnost
tokyo
japan
immunochromatograph
test
use
serum
give
visibl
result
test
repeat
posit
neg
control
prepar
reduc
nonspecif
reaction
antibodi
analys
target
caus
agent
respiratori
diseas
hepat
human
addit
retrovirus
enceph
viru
chimpanze
foami
viru
cfv
specif
antibodi
examin
react
mycoplasma
pneumonia
chlamydia
pneumonia
bordetella
pertussi
japanes
higashihama
yamaguchi
strain
influenza
viru
influenza
b
viru
human
parainfluenza
viru
type
hmpv
rsv
mump
viru
measl
viru
mv
adenoviru
adv
coxsackieviru
type
echoviru
type
enteroviru
polioviru
type
herp
simplex
cytomegaloviru
cmv
varicella
zoster
viru
vzv
epsteinbarr
viru
ebv
human
herpesviru
hepat
viru
hav
hepat
b
viru
hbv
hepat
c
viru
hcv
rubella
viru
reoviru
rotaviru
human
parvoviru
japanes
enceph
viru
jev
human
immunodefici
viru
type
human
cell
lymphotrop
viru
type
cfv
filoviru
entamoeba
histolytica
statist
analysi
student
test
use
compar
averag
antibodi
titr
chimpanze
rear
sinc
birth
sb
chimpanze
rear
birth
ab
p
valu
consid
indic
statist
signific
result
fig
investig
preval
antibodi
humanborn
pathogen
chimpanze
japanes
primat
institut
use
standard
procedur
human
serolog
analysi
tabl
summaris
name
sex
age
histori
year
arriv
kupri
medic
note
chimpanze
six
chimpanze
born
kupri
pal
cleo
ayumu
pan
reo
popo
eight
chimpanze
born
europ
africa
chloe
pendesa
ai
mari
akira
reiko
puchi
gon
seropreval
human
chimpanzeeorigin
pathogen
chimpanze
list
supplementari
tabl
antibodi
human
pathogen
detect
use
standard
procedur
serolog
analysi
human
briefli
chimpanze
posit
high
preval
human
pathogen
pertussi
hmpv
rsv
cmv
vzv
ebv
addit
human
pathogen
found
chimpanze
low
preval
influenza
mv
hav
reoviru
rotaviru
jev
cfv
also
detect
chimpanze
antibodi
follow
pathogen
detect
chimpanze
pneumonia
c
pneumonia
influenza
influenza
b
mump
viru
enteroviru
hsv
hbv
hcv
rubella
viru
filoviru
addit
e
histolytica
posit
posit
sampl
antibodi
titr
equal
cutoff
titr
asterisk
supplementari
tabl
figur
b
b
show
antibodi
titr
pertussi
mv
hmpv
rsv
cmv
vzv
ebv
group
birthplac
chimpanze
sb
indic
chimpanze
rear
kupri
sinc
birth
ab
indic
chimpanze
introduc
rear
kupri
birth
ab
group
older
sb
group
birthplac
list
tabl
pertussi
caus
b
pertussi
infect
antibodi
titr
pertussi
vari
averag
titr
sb
chimpanze
equal
ab
chimpanze
fig
antibodi
titr
mv
averag
titr
ab
chimpanze
fig
one
chimpanze
seropreval
titr
hmpv
rsv
antibodi
obtain
use
hi
elisa
second
two
chimpanze
serum
sampl
titr
sb
chimpanze
rang
ab
chimpanze
rang
averag
titr
sb
group
lower
ab
group
titr
hmpv
sb
chimpanze
rang
lower
ab
chimpanze
averag
titr
sb
group
also
lower
ab
group
titr
hrsv
rang
broadli
sb
ab
chimpanze
averag
titr
sb
chimpanze
much
higher
ab
chimpanze
hollow
box
indic
sb
solid
box
indic
ab
bar
indic
averag
av
posit
mv
sb
group
averag
antibodi
titr
sb
chimpanze
lower
ab
chimpanze
fig
rang
titr
rsv
broad
averag
titr
sb
chimpanze
equal
ab
chimpanze
fig
titr
hmpv
sb
chimpanze
sb
anim
averag
lower
level
ab
chimpanze
averag
fig
titr
hmpv
increas
age
p
examin
specif
antibodi
herpesvirus
captiv
chimpanze
surprisingli
chimpanze
high
preval
antibodi
four
herpesvirus
cmv
vzv
ebv
supplementari
tabl
titr
cmv
vzv
ebv
shown
fig
titr
antibodi
cmv
increas
age
p
human
adv
common
caus
respiratori
eye
urolog
gastrointestin
diseas
speci
adv
caus
pathogen
epidem
keratoconjunct
human
studi
howev
antibodi
detect
three
chimpanze
one
chimpanze
respect
without
specif
symptom
mainli
caus
pharyngoconjunctiv
fever
human
studi
detect
compar
high
seropreval
respect
wherea
detect
one
chimpanze
supplementari
tabl
signific
differ
preval
sb
ab
chimpanze
figur
show
antibodi
titr
chimpanze
seropreval
picornavirus
titr
antibodi
vari
picornaviru
antibodi
found
sb
chimpanze
mari
ab
femal
antibodi
four
picornavirus
akira
ab
male
antibodi
although
rel
low
titr
figur
show
antibodi
titr
chimpanze
seropreval
mosquitoborn
enceph
viru
jev
hav
antibodi
jev
detect
sb
ab
chimpanze
antibodi
hav
detect
ab
chimpanze
survey
whether
captiv
chimpanze
specif
antibodi
humanborn
infecti
pathogen
test
antibodi
infecti
diseas
serum
captiv
chimpanze
found
high
low
fig
seropreval
antibodi
picornavirus
chimpanze
antibodi
serum
detect
use
nt
ab
femal
mari
antibodi
four
picornavirus
ab
male
akira
antibodi
abbrevi
chimpanze
name
list
tabl
b
seropreval
antibodi
hav
jev
chimpanze
detect
use
clia
hav
cf
jev
antibodi
jev
detect
sb
ab
chimpanze
hav
detect
ab
chimpanze
preval
antibodi
therefor
standard
procedur
human
serolog
analysi
may
use
detect
specif
antibodi
humanborn
infecti
pathogen
captiv
chimpanze
data
older
younger
chimpanze
compar
assess
hygien
condit
institut
studi
found
fewer
posit
pathogen
studi
us
primat
centr
conduct
kalter
heberl
year
ago
may
infecti
agent
remov
chimpanze
environ
improv
knowledg
infecti
diseas
antibodi
titr
chimpanze
reduc
undetect
level
time
serolog
test
select
conduct
commerci
laboratori
method
use
test
vari
type
detect
immunoglobulin
ig
test
sensit
differ
henc
ideal
serolog
screen
sever
diseas
assay
detect
mani
ig
chimpanze
produc
ie
igm
iga
igg
ige
howev
monitor
humanborn
pathogen
complic
easili
avail
test
method
requir
public
zoolog
garden
primat
research
institut
could
determin
histori
infect
use
convent
serolog
analys
could
determin
antibodi
titr
decreas
bare
detect
level
serum
samplerel
factor
affect
test
exampl
crossreact
antibodi
chimpanze
virus
human
virus
effect
haemolyt
sampl
contamin
studi
seven
pathogen
detect
titr
equal
standard
cutoff
titr
among
pathogen
virus
common
human
diseas
thu
highli
possibl
may
infect
chimpanze
hand
west
pacif
area
free
poliomyel
sinc
octob
whowpro
kyoto
confer
kyoto
japan
falseposit
case
e
histolytica
infect
report
despit
fact
titr
equal
cutoff
level
tachibana
et
al
thu
conserv
assum
e
histolytica
indetermin
although
titr
normal
deem
posit
chimpanze
foami
viru
common
viru
chimpanze
transmit
varieti
rout
preval
cfv
indic
rear
condit
kupri
provid
environ
spread
among
chimpanze
therefor
human
pathogen
may
directli
transmit
chimpanze
human
may
also
spread
among
chimpanze
pertussi
infect
chimpanze
report
zoolog
garden
sweden
affect
chimpanze
typic
clinic
sign
b
pertussi
infect
gustavssona
et
al
howev
clinic
sign
detect
kupri
chimpanze
despit
higher
antibodi
titr
basi
high
antibodi
titr
chimpanze
kupri
may
infect
recent
may
develop
immun
pertussi
pertussi
human
common
children
efficaci
vaccin
prove
antibodi
titr
decreas
year
henc
perman
immun
establish
adult
may
reinfect
antibodi
level
decreas
exampl
previous
vaccin
adult
japan
recent
reinfect
pertussi
nih
measl
viru
antibodi
found
six
chimpanze
studi
interestingli
one
chimpanze
born
japan
rear
sinc
birth
kupri
sb
specif
antibodi
mv
compar
five
chimpanze
posit
among
born
europ
africa
rear
birth
kupri
ab
peopl
antibodi
titr
mv
antibodi
product
believ
indic
person
acquir
immun
mv
taya
et
al
chimpanze
lower
antibodi
titr
still
risk
mv
infect
rsv
hmpv
antibodi
preval
human
increas
age
preval
hi
test
antibodi
human
peak
kishi
et
al
wherea
hmpv
elisa
peak
okamoto
et
al
antibodi
titr
rsv
chimpanze
vari
age
contrast
human
normal
acquir
immun
adulthood
bhattarakosol
et
al
human
paramyxovirus
hmpv
rsv
caus
sever
diseas
childhood
mild
diseas
adult
acquir
immun
repeat
infect
process
grow
therefor
high
preval
virus
chimpanze
may
indic
kupri
chimpanze
develop
develop
immun
hmpv
rsv
increas
antibodi
preval
age
similar
human
hmpv
rsv
hmpv
outbreak
wild
chimpanze
howev
caus
death
sever
diseas
kaur
et
al
kondgen
et
al
rsv
identifi
chimpanze
coryza
agent
isol
first
time
primat
institut
usa
henc
chimpanze
highli
suscept
rsv
morri
et
al
adenovirus
common
human
infect
lead
diseas
peopl
develop
adequ
immun
reinfect
serotyp
studi
adv
serotyp
found
chimpanze
serum
seropreval
high
supplementari
tabl
chimpanze
adenovirus
also
identifi
chimpanze
adv
pan
neutralis
human
willimzik
et
al
recent
novel
great
ape
adv
chimpanze
bonobo
gorilla
detect
captiv
nonhuman
primat
held
facil
zoolog
garden
north
america
roy
et
al
typic
adv
narrow
host
rang
restrict
one
anim
speci
close
relat
host
speci
wold
herpesvirida
highli
infecti
host
anim
persist
latent
ebv
cmv
like
virus
chimpanze
report
previous
neutralis
antibodi
test
need
distinguish
among
virus
human
chimpanze
origin
gerber
et
al
swinkel
et
al
lacost
et
al
luebck
et
al
studi
chimpanze
posit
ebv
cmv
vzv
posit
antibodi
found
supplementari
tabl
human
antibodi
preval
herpesvirus
increas
age
acquisit
immun
henc
antibodi
preval
cmv
similar
human
repeat
reactiv
herpesvirus
ebv
vzv
may
occur
host
anim
human
herpesvirus
may
transmit
chimpanze
kupri
human
vzv
infect
report
chimpanze
affect
chimpanze
mild
skin
rash
entir
bodi
cohen
et
al
human
vzv
infect
sometim
caus
herp
zoster
thought
trigger
stress
weak
immun
case
sever
haemorrhag
symptom
result
reactiv
origin
vzv
simian
varicella
viru
report
cynomolgu
monkey
takasaka
et
al
howev
although
kupri
chimpanze
antibodi
chimpanze
never
develop
symptom
origin
great
ape
vzv
identifi
high
incid
infect
may
indic
exist
vzvrelat
viru
hsv
common
viru
human
also
primat
howev
transmiss
observ
kupri
chimpanze
jev
arboviru
transmit
mosquito
culex
tritaeniorhynchu
feed
blood
host
pig
seropreval
pig
popul
prefectur
aichi
neighbour
kupri
locat
suggest
rare
even
report
human
resid
suffer
jev
infect
niid
sato
et
al
pan
popo
born
kupri
infect
jev
suggest
jev
occur
region
around
kupri
chimpanze
might
bitten
mosquito
carri
viru
howev
first
report
detect
antibodi
jev
chimpanze
hav
transmit
via
faecalor
rout
outbreak
human
hav
spread
chimpanze
human
chimpanze
chimpanze
report
elsewher
dienstag
et
al
human
host
hav
normal
human
develop
countri
infect
childhood
acquir
immun
three
seroposit
chimpanze
born
africa
might
infect
childhood
fig
hav
infect
rare
japan
case
import
therefor
transmiss
might
ever
occur
chimpanze
kupri
among
picornavirida
infect
poliomyel
polioviru
clinic
import
diseas
among
enterovirus
studi
chimpanze
posit
high
incid
viru
caus
herpangina
human
children
reiko
akira
seroposit
sever
picornavirus
indic
may
infect
differ
person
without
chimpanzeetochimpanze
transmiss
influenza
viru
preval
human
age
ayumu
antibodi
sever
symptom
influenza
infect
may
forc
worker
enter
rear
zone
chanc
transmiss
may
decreas
manag
captiv
chimpanze
zoonot
risk
human
import
issu
examin
futur
studi
whether
caretak
specif
antibodi
humanborn
infecti
pathogen
captiv
chimpanze
one
task
zoo
research
institut
protect
maintain
endang
speci
includ
chimpanze
therefor
import
keep
chimpanze
healthi
condit
quit
differ
nativ
habitat
may
difficult
small
zoo
research
institut
establish
examin
system
success
detect
chimpanze
antibodi
human
pathogen
use
commerci
test
develop
human
facilit
routin
monitor
surveil
captiv
chimpanze
continu
serolog
examin
analys
antibodi
level
respiratori
pathogen
furthermor
data
limit
one
institut
inform
gather
use
great
ape
conserv
studi
perform
onepoint
serolog
surveil
provid
histori
chimpanze
therefor
phase
examin
perform
analys
diseas
preval
futur
studi
focuss
transmiss
humanborn
infect
chimpanze
revers
also
consid
human
emerg
diseas
zoonot
origin
wildlif
via
direct
indirect
contact
exampl
case
ebola
viru
infect
result
contact
infect
wild
chimpanze
morel
le
guenno
et
al
taylor
et
al
chimpanze
caretak
research
risk
exposur
unknown
chimpanze
infecti
pathogen
addit
basic
hygien
keeper
research
need
appropri
vaccin
wear
mask
glove
protect
cloth
quarantin
period
studi
provid
import
inform
hygien
manag
wild
chimpanze
conserv
ad
inform
possibl
humanchimpanze
zoonot
diseas
infecti
agent
newli
identifi
antibodi
agent
possibl
transmitt
chimpanze
jev
previous
detect
pathogen
might
caus
next
outbreak
wild
chimpanze
primat
institut
also
zoolog
garden
furthermor
consid
agent
seroposit
chimpanze
chimpanze
possess
immun
least
antibodi
chimpanze
kupri
unlik
group
wild
chimpanze
previou
infect
rsv
hmpv
caus
sever
respiratori
diseas
captiv
chimpanze
might
opportun
expos
human
pathogen
compar
wild
popul
environ
diet
might
harsh
wild
could
alter
incid
effect
pathogen
captiv
wild
popul
addit
captiv
chimpanze
risk
new
infecti
diseas
never
expos
establish
immun
consequ
monitor
result
analys
care
research
institut
zoo
care
taken
pathogen
includ
chimpanze
highli
suscept
chimpanze
seroposit
ultim
without
direct
surveil
wild
popul
elucid
preval
humanborn
infecti
diseas
wild
data
may
still
use
model
data
suggest
mean
detect
antibodi
faec
develop
facilit
studi
wild
recent
year
vaccin
program
protect
wild
chimpanze
ebola
viru
plan
prepar
walsh
vaccin
challeng
polio
viru
wild
chimpanze
gomb
measl
viru
gorilla
virunga
whittier
et
al
furthermor
effect
report
one
case
intervent
robbin
et
al
studi
show
group
chimpanze
captiv
condit
produc
specif
antibodi
human
diseas
chimpanze
probabl
protect
acquir
immun
therefor
preimmun
probabl
effect
protect
wild
chimpanze
human
infecti
diseas
tourist
research
unknowingli
transmit
howev
vaccin
campaign
need
care
consider
term
neg
side
effect
wild
chimpanze
natur
recent
ryan
walsh
review
posit
neg
intervent
describ
avail
vaccin
human
pathogen
conduct
serolog
surveil
humanborn
zoonos
chimpanze
reveal
possibl
diseas
transmiss
human
chimpanze
reduc
chanc
transmit
diseas
captiv
chimpanze
research
institut
zoo
prevent
diseas
transmiss
among
research
anim
caretak
chimpanze
necessari
evalu
risk
diseas
transmiss
serolog
captiv
chimpanze
provid
import
inform
hygien
manag
ecotour
involv
wild
chimpanze
great
ape
